Kyohara M, Takayanagi R, Tsuno T, Ong Yajima E, Inoue R, Yamashita N, Okuyama T, Nishiyama K, Matsunaga K, Ishida E, Ito S, Terauchi Y, Goshima Y, *Shirakawa J. Expression analysis and possible functional roles of semaphorin/plexin/CRMP families in mouse pancreatic islets. Sci Rep. 15(1):10546, 2025. （*責任著者：白川純）
Sato K, Ogasawara H, Ikeda Y, Kumagai H, Inoue R, Tsuno T, Matsunaga K, Ishida E, *Shirakawa J. The antitumor effects of metformin are potentially mediated through LPA receptor inhibition. Diabetes Res Clin Pract. 222:112094, 2025. （*責任著者：白川純）
Okuyama T, Tsuno T, Inoue R, Fukushima S, Kyohara M, Matsumura A, Miyashita D, Nishiyama K, Takano Y, Togashi Y, Meguro-Horike M, Horike S, Kin T, Shapiro AMJ, Yanagisawa H, Terauchi Y, *Shirakawa J. The matricellular protein Fibulin-5 regulates β-cell proliferation in an autocrine/paracrine manner. iScience. 28(2):111856, 2025. （*責任著者：白川純）
Tahiri A, Youssef A, Inoue R, Moon S, Alsarkhi L, Berroug L, Nguyen XTA, Wang L, Kwon H, Pang ZP, Zhao JY, Shirakawa J, Ulloa L, El Ouaamari A. Vagal sensory neuron-derived FGF3 controls insulin secretion. Dev Cell. 60:51-61, 2024.
Honda M, Inoue R, Nishiyama K, Ueda T, Komuro A, Amano H, Sugisawa R, Dash S, Shirakawa J, Okada H. Vgll2 as an integrative regulator of mitochondrial function and contractility specific to skeletal muscle. J Cell Physiol. 239(12):e31436, 2024.
Terui S, Igari M, Tsuno T, Okuyama T, Inoue R, Kyohara M, Terauchi Y, *ShirakawaJ. Immediate impact of switching from dipeptidyl peptidase-4 (DPP-4) inhibitors to low-dose (0.3 mg) liraglutide on glucose profiles: A retrospective observational study. Diabetes Ther. in press, 2024.（*責任著者：白川純）
Moon S, Alsarkhi L, Lin TT, Inoue R, Tahiri A, Colson C, Cai W, Shirakawa J, Qian WJ, Zhao JY, *El Ouaamari A. Transcriptome and secretome profiling of sensory neurons reveals sex differences in pathways relevant to insulin sensing and insulin secretion. FASEB J. 37(10):e23185, 2023.
#Nishiyama K, #Ono M, Tsuno T, Inoue R, Fukunaka A, Okuyama T, Kyohara M, Togashi Y, Fukushima S, Atsumi T, Sato A, Tsurumoto A, Sakai C, Fujitani Y, Terauchi Y, Ito S, *Shirakawa J. Protective effects of imeglimin and metformin combination therapy on β-cells in db/db male mice. Endocrinology. 164(8): bqad095, 2023.（#:共筆頭著者、*責任著者：白川純）
Arai M, Tsuno T, Konishi H, Nishiyama K, Terauchi Y, Inoue R, *Shirakawa J. A disproportionality analysis of the adverse effect profiles of methimazole and propylthiouracil in patients with hyperthyroidism using the Japanese Adverse Drug Event Report Database. Thyroid. in press, 2023. （*責任著者：白川純）
Fukunaka A, Shimura M, Ichinose T, Pereye OB, Nakagawa Y, Tamura Y, Mizutani W, Inoue R, Inoue T, Tanaka Y, Sato T, Saitoh T, Fukada T, Nishida Y, Miyatsuka T, Shirakawa J, Watada H, Matsuyama S, *Fujitani Y. Zinc and iron dynamics in human islet amyloid polypeptide-induced diabetes mouse model. Sci Rep. 13(1): 3484, 2023.
#Miyashita D, #Inoue R, Tsuno T, Okuyama T, Kyohara M, Nakahashi-Oda C, Nishiyama K, Fukushima S, Inada Y, Togashi Y, Shibuya A, Terauchi Y, *Shirakawa J. Protective effects of S100A8 on sepsis mortality: links to sepsis risk in obesity and diabetes. iScience. 25(12):105662, 2022. （#:共筆頭著者、*責任著者：白川純）
Kyohara M, Miyashita D, Inoue R, .. *Shirakawa J. Association between circulating SerpinB1 levels and insulin sensitivity in Japanese with type 2 diabetes: A single-center, cross-sectional, observational study. PLoS One. 17(11):e0276915, 2022. （*責任著者：白川純）
*Shirakawa J, Togashi Y, Basile G, Okuyama T, Inoue R, .. Shapiro AMJ, Yi P, Terauchi Y, *Kulkarni RN. E2F1 transcription factor mediates a link between fat and islets to promote β-cell proliferation in response to acute insulin resistance. Cell Rep. 41(1): 111436, 2022.（*責任著者：白川純）
Togashi Y, Miyashita D, Tsuno T, Inoue R, .. *Shirakawa J. Abdominal aortic calcification is associated with Fibrosis-4 index and low body mass index in type 2 diabetes: a retrospective cross-sectional study. J Diabetes Investig. 13(11):1861-1872, 2022.（*責任著者：白川純）
